Anticancer drugs designed by mother nature: ancient drugs but modern targets

Haruyo Ichikawa1, Yutaka Nakamura, Yoshiki Kashiwada

  • 1International Research and Educational Institute for Integrated Medical Sciences (IREIIMS), Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Insights

Nuclear factor-kappaBeta (NF-kappaBeta) is crucial in cancer and inflammation. This review highlights fruits and vegetables as natural sources of NF-kappaBeta inhibitors, offering potential for cancer prevention and treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Nuclear factor-kappaBeta (NF-kappaBeta) is a key transcription factor activated by diverse stimuli, including inflammatory agents, carcinogens, and stresses.
  • Constitutively active NF-kappaBeta is prevalent in various tumors, regulating over 400 genes linked to cancer progression, inflammation, and metastasis.
  • NF-kappaBeta's critical role in pathogenesis necessitates the search for specific inhibitors for cancer and inflammation prevention.

Purpose of the Study:

  • To review evidence on agents from fruits and vegetables that inhibit the NF-kappaBeta pathway.
  • To explore the relationship between drug structure and NF-kappaBeta inhibitory activity.
  • To re-evaluate traditional medicine's potential in light of modern scientific understanding for therapeutic and preventive applications.

Main Methods:

  • Literature review of studies investigating NF-kappaBeta inhibitors.
  • Analysis of plant-derived compounds, particularly from fruits and vegetables.
  • Discussion of structure-activity relationships for NF-kappaBeta inhibition.

Main Results:

  • Numerous agents from fruits and vegetables demonstrate interference with the NF-kappaBeta pathway.
  • Ancient plants and their components are identified as potent NF-kappaB inhibitors.
  • The review discusses the structural basis for the inhibitory activity of these agents.

Conclusions:

  • Fruits and vegetables contain compounds that can inhibit the NF-kappaBeta pathway, suggesting a role in cancer prevention.
  • Rediscovering and validating traditional medicine principles with modern scientific methods is crucial for developing new therapies.
  • Understanding the structure-activity relationship of natural compounds can guide the development of novel NF-kappaBeta inhibitors.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...